Telix Pharmaceuticals Correlations
| TLPPF Stock | USD 14.56 0.50 3.56% |
The current 90-days correlation between Telix Pharmaceuticals and Keros Therapeutics is -0.05 (i.e., Good diversification). The correlation of Telix Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Telix Pharmaceuticals Correlation With Market
Average diversification
The correlation between Telix Pharmaceuticals Limited and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and DJI in the same portfolio, assuming nothing else is changed.
Telix |
The ability to find closely correlated positions to Telix Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telix Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telix Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telix Pharmaceuticals Limited to buy it.
Moving together with Telix Pink Sheet
| 0.81 | STLD | Steel Dynamics Fiscal Year End 28th of January 2025 | PairCorr |
| 0.75 | CRWD | Crowdstrike Holdings | PairCorr |
| 0.72 | ADSK | Autodesk | PairCorr |
| 0.68 | ALAB | Astera Labs, Common | PairCorr |
| 0.79 | NVDA | NVIDIA | PairCorr |
| 0.67 | APLD | Applied Blockchain | PairCorr |
| 0.62 | MRVL | Marvell Technology Earnings Call This Week | PairCorr |
Moving against Telix Pink Sheet
| 0.84 | EPGG | Empire Global Gaming | PairCorr |
| 0.78 | NVO | Novo Nordisk AS | PairCorr |
| 0.78 | NONOF | Novo Nordisk AS | PairCorr |
| 0.77 | QSAM | Qsam Biosciences | PairCorr |
| 0.71 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.65 | AMIX | Autonomix Medical, Common Downward Rally | PairCorr |
| 0.58 | TPDDF | Talon Energy | PairCorr |
| 0.54 | CSLLY | CSL | PairCorr |
| 0.52 | SGEN | Seagen Inc | PairCorr |
| 0.51 | IMHC | Imperalis Holding Corp | PairCorr |
| 0.43 | CMXHF | CSL Limited | PairCorr |
| 0.36 | GBHPF | Global Hemp Group | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Telix Pink Sheet performing well and Telix Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Telix Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GNNSF | 0.78 | (0.20) | 0.00 | 0.77 | 0.00 | 0.00 | 18.45 | |||
| KROS | 2.06 | 0.19 | 0.10 | 0.26 | 2.13 | 4.39 | 16.94 | |||
| ZNTL | 4.20 | (0.03) | 0.03 | 0.11 | 5.20 | 11.41 | 33.76 | |||
| IVBXF | 1.84 | (0.11) | 0.00 | (1.18) | 0.00 | 5.48 | 24.34 | |||
| MAIA | 3.89 | (0.51) | 0.00 | (0.52) | 0.00 | 8.37 | 28.10 | |||
| GRPH | 2.36 | (0.08) | 0.00 | 0.54 | 0.00 | 4.79 | 14.40 | |||
| ROIVW | 4.02 | 0.59 | 0.11 | 1.25 | 4.20 | 8.80 | 24.42 | |||
| FTHWF | 1.54 | (0.37) | 0.00 | 0.62 | 0.00 | 0.00 | 30.40 | |||
| NAUT | 2.91 | (0.34) | 0.00 | (0.01) | 0.00 | 6.02 | 17.43 | |||
| ACLX | 2.42 | 0.16 | 0.09 | 0.19 | 2.81 | 6.28 | 15.13 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Telix Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Telix Pharmaceuticals Corporate Management
| Jyoti BappSc | Chief APAC | Profile | |
| Meredith Crowe | Interim Culture | Profile | |
| BSc BSc | Chief Scientist | Profile | |
| Christian Davis | EMEA Marketing | Profile | |
| Andreas MD | Chief Director | Profile | |
| Amanda Griffin | Communications Mang | Profile | |
| BEng DPhil | Group CoFounder | Profile |